Vitamin D and type 2 diabetes

Clinical Reviews in Bone and Mineral Metabolism

Volumn 7, Issue 2, 2009, Pages 185-198

  Eliades, Myrto ^a   Pittas, Anastassios G ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Calcium; Type 2 diabetes; Vitamin D

Indexed keywords

EID: 84905113874     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-009-9041-y     Document Type: Article

References (96)

1. Narayan KM, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care. 2006;29(9):2114-6. (Pubitemid 44871196)
2. Wild S, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. (Pubitemid 38579764)
3. Dabelea D, et al. Incidence of diabetes in youth in the United States. Jama. 2007;297(24):2716-24. (Pubitemid 47001097)
4. Booth GL, et al. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006;368(9529):29-36. (Pubitemid 43947203)
5. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-32.
6. Hu FB, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345(11):790-7.
7. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. (Pubitemid 34437694)
8. Pittas AG, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017-29. (Pubitemid 46997093)
9. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116(8):2062-72. (Pubitemid 44162310)
10. Fleet JC. Rapid, membrane-initiated actions of 1,25-dihydroxyvitamin D: what are they and what do they mean? J Nutr. 2004;134(12):3215-8. (Pubitemid 39602987)
11. Norman AW, et al. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209(4458):823-5. (Pubitemid 10017495)
12. Kadowaki S, Norman AW. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest. 1984;73(3):759-66. (Pubitemid 14156858)
13. Tanaka Y, et al. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol (Copenh). 1984;105(4):528-33. (Pubitemid 14171181)
14. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986;119(1):84-90. (Pubitemid 16100711)
15. Bourlon PM, Faure-Dussert A, Billaudel B. The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1,25-dihydroxyvitamin D3 repletion in the islets of langerhans of rats. J Endocrinol. 1999;162(1):101-9. (Pubitemid 29336360)
16. Clark SA, Stumpf WE, Sar M. Effect of 1,25-dihydroxyvitamin D3 on insulin secretion. Diabetes. 1981;30(5):382-6.
17. Johnson JA, et al. Immunohistochemical localization of the 1, 25(OH)2D3 receptor and calbindin D28 k in human and rat pancreas. Am J Physiol. 1994;267(3 pt 1):E356-60.
18. Zeitz U, et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. Faseb J. 2003;17(3):509-11.
19. Maestro B, et al. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84(2-3):223-30. (Pubitemid 36514839)
20. Maestro B, et al. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct. 2002;20(3):227-32.
21. Bland R, et al. Expression of 25-hydroxyvitamin D3-1alphahydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89-90(1-5):121-5.
22. Sergeev IN, Rhoten WB. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. Endocrinology. 1995;136(7):2852-61.
23. Milner RD, Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia. 1967;3(1):47-9.
24. Kadowaki S, Norman AW. Pancreatic vitamin D-dependent calcium binding protein: biochemical properties and response to vitamin D. Arch Biochem Biophys. 1984;233(1):228-36. (Pubitemid 14071019)
25. Sooy K, et al. Calbindin-D (28 k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-D (28 k) knockout mice and beta cell lines. J Biol Chem. 1999;274(48):34343-9. (Pubitemid 129511777)
26. Maestro B, et al. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000;47(4):383-91.
27. Dunlop TW, et al. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha, 25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol. 2005;349(2):248-60. (Pubitemid 40693747)
28. Ojuka EO. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc. 2004;63(2):275-8. (Pubitemid 38787478)
29. Wright DC, et al. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes. 2004;53(2):330-5. (Pubitemid 38174547)
30. Draznin B, et al. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem. 1987;262(30):14385-8. (Pubitemid 17157352)
31. Byyny RL, et al. Cytosolic calcium and insulin resistance in elderly patients with essential hypertension. Am J Hypertens.1992;5(7):459-64.
32. Draznin B, et al. Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology. 1989;125(5):2341-9. (Pubitemid 19279417)
33. Draznin B, et al. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest. 1988;82(6):1848-52. (Pubitemid 19054929)
34. Draznin B, et al. Relationship between cytosolic free calcium concentration and 2-deoxyglucose uptake in adipocytes isolated from 2- and 12-month-old rats. Endocrinology. 1988;122(6):2578-83.
35. Ohno Y, et al. Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens. 1993;11(4):421-6. (Pubitemid 23139785)
36. Segal S, et al. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus. Horm Res. 1990;34(1):39-44.
37. Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem. 1998;188(1-2):129-36. (Pubitemid 28493325)
38. Williams PF, et al. High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+. Cell Calcium. 1990;11(8):547-56. (Pubitemid 20336058)
39. Reusch JE, et al. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology. 1991;129(6):3269-73.
40. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol. 2004;286(5):H1597-602. (Pubitemid 38525443)
41. Wei Y, et al. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase. Am J Physiol Endocrinol Metab. 2008;294(2):E345-51. (Pubitemid 351231460)
42. Li YC, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-38. (Pubitemid 34787360)
43. Yuan W, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282(41):29821-30. (Pubitemid 350035242)
44. Duncan BB, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003;52(7):1799-805. (Pubitemid 36792473)
45. Hu FB, et al. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53(3):693-700. (Pubitemid 38270639)
46. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab. 2004;89(2):447-52. (Pubitemid 38269842)
47. Pradhan AD, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama. 2001;286(3):327-34. (Pubitemid 32656163)
48. Riachy R, et al. 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology. 2002;143(12):4809-19. (Pubitemid 35397621)
49. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97(1-2):93-101.
50. Riachy R, et al. 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis. 2006;11(2):151-9. (Pubitemid 43291016)
51. Giulietti A, et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract. 2007;77(1):47-57. (Pubitemid 46590467)
52. Behall KM, et al. Seasonal variation in plasma glucose and hormone levels in adult men and women. Am J Clin Nutr. 1984;40(6 Suppl):1352-6. (Pubitemid 15193051)
53. Campbell IT, Jarrett RJ, Keen H. Diurnal and seasonal variation in oral glucose tolerance: studies in the Antarctic. Diabetologia. 1975;11(2):139-45.
54. Aksoy H, et al. Serum 1,25-dihydroxy vitamin D (1,25(OH)2D3), 25-hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem. 2000;33(1):47-51. (Pubitemid 30313043)
55. Boucher BJ, et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995;38(10):1239-45.
56. Christiansen C, et al. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D. Scand J Clin Lab Invest. 1982;42(6):487-91. (Pubitemid 12030397)
57. Cigolini M, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2006;29(3):722-4. (Pubitemid 44115386)
58. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006;29(10):2244-6. (Pubitemid 44899859)
59. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001;24(8):1496.
60. Nyomba BL, et al. Vitamin D metabolites and their binding protein in adult diabetic patients. Diabetes. 1986;35(8):911-5. (Pubitemid 16014444)
61. Pietschmann P, Schernthaner G, Woloszczuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia. 1988;31(12):892-5. (Pubitemid 19054759)
62. Scragg R, et al. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995;27(3):181-8.
63. Stepan J, et al. Plasma 25-hydroxycholecalciferol in oral sulfonylurea treated diabetes mellitus. Horm Metab Res. 1982;14(2):98-100. (Pubitemid 12166848)
64. Heath HIII, et al. Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab. 1979;49(3):462-6.
65. Ishida H, et al. Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes. Metabolism. 1985;34(9):797-801. (Pubitemid 15239308)
66. Baynes KC, et al. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia. 1997;40(3):344-7. (Pubitemid 27096561)
67. Chiu KC, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820-5. (Pubitemid 41103882)
68. Ford ES, et al. Concentrations of serum vitamin D and the metabolic syndrome among U. S. adults. Diabetes Care. 2005;28(5):1228-30. (Pubitemid 40616645)
69. Martins D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167(11):1159-65. (Pubitemid 46919818)
70. Need AG, et al. Relationship between fasting serum glucose, age, body mass index and serum 25-hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf). 2005;62(6):738-41. (Pubitemid 40825945)
71. Reis JP, et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30(6):1549-55. (Pubitemid 46871169)
72. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813-8. (Pubitemid 39565042)
73. Botella-Carretero JI, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26(5):573-80. (Pubitemid 47618319)
74. Hypponen E, et al. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008;57(2):298-305.
75. Liu S, et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28(12):2926-32. (Pubitemid 43942926)
76. McGill AT, et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008;7:4.
77. Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994;59(5):1083-7.
78. Snijder M, et al. To: Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes, Diabetologia 48:1247-1257. Diabetologia. 2006;49(1):217-8. (Pubitemid 43151637)
79. Wareham NJ, et al. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism. 1997;46(10):1171-7. (Pubitemid 27418507)
80. Bell NH, et al. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest. 1985;76(2):470-3. (Pubitemid 15227507)
81. Parikh SJ, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89(3):1196-9. (Pubitemid 38368412)
82. Wortsman J, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690-3. (Pubitemid 30667088)
83. Pittas AG, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006;29(3):650-6. (Pubitemid 44115368)
84. Mattila C, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30(10):2569-70. (Pubitemid 47547796)
85. Knekt P, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19:666-71.
86. van Dam RM, et al. Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care. 2006;29(10):2238-43.
87. Pereira MA, et al. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. Jama. 2002;287(16):2081-9. (Pubitemid 34437343)
88. Fliser D, et al. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest. 1997;27(7):629-33. (Pubitemid 27320041)
89. Inomata S, et al. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner. 1986;1(3):187-92. (Pubitemid 16015701)
90. Ljunghall S, et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance - a prospective randomized double-blind study. Acta Med Scand. 1987;222(4):361-7. (Pubitemid 18049118)
91. Nilas L, Christiansen C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes. 1984;8(5):407-11. (Pubitemid 15215948)
92. de Boer IH, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008;31(4):701-7.
93. Jacobs DR Jr, Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy. Am J Clin Nutr. 2003;78(3 Suppl):508S-13S. (Pubitemid 40012541)
94. Nutrient Food Board, I.o.M. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy Press; 2003.
95. Bischoff-Ferrari HA, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28. (Pubitemid 44699167)
96. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135(2):317-22. (Pubitemid 40194499)